Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation
- 2 November 2010
- journal article
- Published by Wiley in BJU International
- Vol. 108 (2b) , E77-E83
Abstract
What’s known on the subject? and What does the study add? We found that resistin, a member of adipokine family, is expressed in human prostate cancers and induces prostate cancer cell proliferation through PI3K/Akt signaling pathways. We are studying the effect of resistin on other urogenital tract diseases besides prostate cancer, and the relationship between other adipokines and the urogenital tract diseases. OBJECTIVES: • To determine whether resistin, a novel adipokine, induces prostate cancer cell proliferation. • To identify the mechanisms underlying the activation of prostate cancer cells by resistin. MATERIALS AND METHODS: • Semi‐quantitative reverse transcriptase‐polymerase chain reaction and immunohistochemical staining were performed to investigate the intensity of prostate epithelial resistin expression. • Human full‐length resistin gene (RETN) was transfected into the PC‐3 cells using the pEGFP‐N1 vector to assess the effect of overexpression of resistin in prostate cancer cell line PC‐3. • Various concentrations of human recombinant protein resistin were added to the hormone‐insensitive prostate cancer cell lines PC‐3 and DU‐145 for 48 h, and cell proliferation was assessed by a water‐soluble tetrazolium salt assay. RESULTS: • Human prostate cancer cell lines PC‐3 and DU‐145 were found to express the human resistin mRNA. • Resistin protein was strongly detected in high‐grade prostate cancer tissue, whereas BPH or low‐grade prostate cancer tissue revealed fainter expression of resistin. • Cell proliferation was stimulated by both the full‐length resistin gene overexpression and resistin treatment. • Akt phosphorylation occurred after addition of resistin to PC‐3 and DU‐145 cells. LY294002, a pharmacological inhibitor of phosphatidylinositol 3‐kinase (PI3K), significantly inhibited PC‐3 and DU‐145 cell proliferation after resistin treatment. CONCLUSIONS: • Resistin is expressed in human prostate cancers. • Resistin induces prostate cancer cell proliferation through PI3K/Akt signalling pathways. • The proliferative effect of resistin on prostate cancer cells may account in part for prostate cancer progression.Keywords
This publication has 37 references indexed in Scilit:
- Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathwaysOncogene, 2009
- Prognostic Value of Akt-1 in Human Prostate Cancer: A Computerized Quantitative Assessment with Quantum Dot TechnologyClinical Cancer Research, 2009
- Relation of Resistin to Prostate Cancer Differentiation and AggressivenessKorean Journal of Urology, 2009
- Relationship of Serum Adiponectin and Resistin Levels with Breast Cancer RiskJournal of Korean Medical Science, 2007
- Resistin Promotes Smooth Muscle Cell Proliferation Through Activation of Extracellular Signal–Regulated Kinase 1/2 and Phosphatidylinositol 3-Kinase PathwaysCirculation, 2004
- TNF-α-mediated apoptosis in normal human prostate epithelial cells and tumor cell linesCancer Letters, 2004
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Preliminary experience with resistin assessment in common population.Biomedical Papers, 2002
- Plasma Resistin Levels in Patients with Type 1 and Type 2 Diabetes Mellitus and in Healthy ControlsHormone and Metabolic Research, 2002
- Human Resistin Gene: Molecular Scanning and Evaluation of Association with Insulin Sensitivity and Type 2 Diabetes in CaucasiansThe Journal of Clinical Endocrinology & Metabolism, 2002